Xian Deng analyst UBS

Currently out of the existing stock ratings of Xian Deng, 1 are a BUY (14.29%), 6 are a HOLD (85.71%).

Xian Deng

Work Performance Price Targets & Ratings Chart

Analyst Xian Deng, currently employed at UBS, carries an average stock price target met ratio of 100% that have a potential upside of 15.55% achieved within 228 days.

Xian Deng’s has documented 10 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 20-Dec-2024.

Wall Street Analyst Xian Deng

Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 5/31/2023. The price target of $480 was fulfilled within 47 days with a profit of $91.3 (23.49%) receiving and performance score of 5.

Average potential price target upside

ABCM Abcam PLC GMAB Genmab AS ARGX argenx NV ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$24

$0.01 (0.04%)

$25

1 years 3 months 21 days ago
(31-Oct-2023)

2/5 (40%)

$1.08 (4.71%)

32

Hold

$25.45

1 years 8 months 1 days ago
(20-Jun-2023)

3/4 (75%)

$9.28 (57.39%)

214

Hold

$19

$-4.99 (-20.80%)

$19

1 years 8 months 9 days ago
(12-Jun-2023)

2/2 (100%)

$1.2 (6.74%)

44

Hold

$17

$-6.99 (-29.14%)

1 years 10 months 30 days ago
(22-Mar-2023)

1/1 (100%)

$3.64 (27.25%)

40

Hold

$19.66

$-4.33 (-18.05%)

$24.41

2 years 11 months 5 days ago
(16-Mar-2022)

4/4 (100%)

$2.49 (14.50%)

287

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Xian Deng is most bullish on?

Potential upside of $0 has been obtained for ARGX (ARGENX NV ADR)

What Year was the first public recommendation made by Xian Deng?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?